AI-generated compounds hit specific cell types and outperform conventional screening

- AI is rewriting biology. New compounds generated by AI hit specific cell types, outperforming conventional screening. No known target? No problem. This is the end of trial-and-error. We are moving from wet labs to silicon-driven discovery. Imagine patents filed by algorithms and chips optimizing molecular structures in real-time. This isn't just medicine; it's computational alchemy. The future of pharma is code. Are you ready to invest in the algorithm that cures the incurable? The race for digital health dominance has begun. #AI #Biotech #CryptoTech